Insider · CIK 0001491140
David D O'Toole
cfoofficer
Files at RCEL (AVITA Medical, Inc.). First filing Dec 5, 2024, latest Aug 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
5 / 0
$51k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCEL: AVITA Medical, Inc.
RCELOct 9, 2026 · close 13.21
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | AVITA Medical, Inc. | $9,040 2,000 shares | +7% | +7% from low-68% from high | |
| 41Moderate | AVITA Medical, Inc. | $9,620 2,000 shares | +7% | +30% from low-61% from high | |
| 39Weak | AVITA Medical, Inc. | $9,900 1,000 shares | +4% | +17% from low-29% from high | |
| 39Weak | AVITA Medical, Inc. | $10k 1,000 shares | +4% | +21% from low-27% from high | |
| 30Weak | AVITA Medical, Inc. | $12k 975 shares | +4% | +30% from low-7% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +2,000 | $4.52 | $9,040 | 31,657 | Aug 26, 2025 |
| Aug 12, 2025 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +2,000 | $4.81 | $9,620 | 29,657 | Aug 12, 2025 |
| May 30, 2025 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +1,923 | $4.78 | $9,186 | 27,657 | Jun 2, 2025 |
| Feb 20, 2025 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +1,000 | $9.90 | $9,900 | 25,734 | Feb 20, 2025 |
| Feb 19, 2025 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +1,000 | $10.25 | $10k | 24,734 | Feb 19, 2025 |
| Jan 21, 2025 | RCEL AVITA Medical, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Jan 22, 2025 |
| Nov 29, 2024 | RCEL AVITA Medical, Inc. | AGrant or award Common Stock | +785 | $7.83 | $6,147 | 22,759 | Dec 5, 2024 |
| Dec 5, 2024 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +475 | $12.53 | $5,952 | 23,234 | Dec 5, 2024 |
| Dec 5, 2024 | RCEL AVITA Medical, Inc. | POpen-market purchase Common Stock | +500 | $12.40 | $6,200 | 23,734 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.